Abbreviated Breast Magnetic Resonance Imaging for Supplemental Screening of Women With Dense Breasts and Average Risk.
Susan P WeinsteinKatrina KorhonenClaire CirelliMitchell D SchnallElizabeth S McDonaldAustin R PantelSamantha P ZuckermanArijitt BorthakurSally D HerschornPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)
Preliminary results from clinical implementation of screening AB-MR resulted in a CDR of 27.4/1,000 at the patient level after DBT in women with dense breasts. Additional evaluation is warranted.